Overview

Varenicline Light Smoking Pilot

Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to assess varenicline vs. placebo for its effect on decreasing cue reactivity in light and intermittent smokers.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Treatments:
Varenicline